Skip to search.
 TSX Down 0.80% TSX Ventures  0.00%
Streaming
Ticker Tape: On

Novo Nordisk A/S (NVO)

-NYSE

158.76 Jun 19, 4:03PM EDT|Pre-Market : 158.11 Down 0.75 (0.47%) 8:15AM EDT - Nasdaq Real Time Price

Add to Portfolio
Prev Close:158.76
Open:N/A
Bid:157.92 x 100
Ask:158.06 x 100
1y Target Est:199.15
Beta:1.06
Next Earnings Date:N/A
Day's Range:N/A - N/A
52wk Range:135.77 - 194.44
Volume:900
Avg Vol (3m):262,473
Market Cap:85.98B
P/E (ttm):22.02
EPS (ttm):7.21
Div & Yield:2.26 (1.40%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
NVO 0.00%85.98B
TEVA 0.00%33.48B
AGN 0.00%29.43B
FRX 0.00%11.16B

Key Statistics

Forward P/E (1 yr):19.43
P/S (ttm):6.17
Ex-Dividend Date:21-Mar-13

Analysts

Annual EPS Est (Dec-12) :N/A
Quarterly EPS Est (Jun-12) :N/A
Mean Recommendation*:1.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Novo Nordisk A/S engages in the discovery, development, manufacture, and marketing of pharmaceutical products primarily in Denmark. It operates in two segments, Diabetes Care and Biopharmaceuticals. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback